Yes pls switch to TG or supermax. Bottling counter already over goreng and without strong fundalmental. Purely on vaccine rumours.Buy more will only trap more.
all this bottling counter going up makes no sense at all, better go buy companies that manufacture bottles , higher profit margin than these repackage companies
KUALA LUMPUR: Pharmaniaga Berhad, a prospect to distribute Covid-19 vaccine, said it will not be making substantial investment for the bottling of the vaccine at is plant in Puchong.
Big boys holding the counter since Rm 1. On rumours that vaccine approve today lah tomorrowlah friday lah..., all on rumours bring this counter up to Rm 6. Big boys sell , make 500%. Small ikan bilis buy at rm 6, koyak .
RM2 million only? That's so minimal. Some uncle auntie also took out RM1 million to buy shares. It seems more like the company directors will be making money by selling their share at high price.
KUALA LUMPUR: Pharmaniaga Berhad, a prospect to distribute Covid-19 vaccine, said it will not be making substantial investment for the bottling of the vaccine at is plant in Puchong.
KUALA LUMPUR: Pharmaniaga Berhad, a prospect to distribute Covid-19 vaccine, said it will not be making substantial investment for the bottling of the vaccine at is plant in Puchong.
With 2mil investment How to make big bucks? How to justify current price? Whats their expected return for vaccine bottling ? 2mil? Aiyo thats tan sri wee lim chai lunch money u know?
Pharmaniaga to invest RM2 million only? Some of you spent RM750K to purchase a house, RM100K for renovations and furniture. Another RM150K for a car. That's already RM1 million
KUALA LUMPUR: Pharmaniaga Berhad, a prospect to distribute Covid-19 vaccine, said it will not be making substantial investment for the bottling of the vaccine at is plant in Puchong.
“There has to be a sterile environment for the vaccine to be bottled. We already have it, and it is furthermore a good manufacturing practice-approved plant. We can bottle the Covid-19 vaccine immediately once it is ready. Our capacity is around 10 million doses per month on 10 doses vial.
Only 2M additional investment needed to accommodate the need as they have the existing plant la sorchai.
if only 2mil budget I also want to invest and compete in this tender. So many glove sour grape.
KUALA LUMPUR: The selection of companies to package the Covid-19 vaccine, once it is found, will not be limited to Pharmaniaga and Duopharma, the Dewan Rakyat was told today. Khairy said several companies have withdrawn from participating in the clinical trial in Malaysia due to the relatively small number of Covid-19 patients in the country as such a process normally required a large number of patients.
KUALA LUMPUR: Pharmaniaga Berhad, a prospect to distribute Covid-19 vaccine, said it will not be making substantial investment for the bottling of the vaccine at is plant in Puchong.
KUALA LUMPUR: The selection of companies to package the Covid-19 vaccine, once it is found, will not be limited to Pharmaniaga and Duopharma, the Dewan Rakyat was told today. Khairy said several companies have withdrawn from participating in the clinical trial in Malaysia due to the relatively small number of Covid-19 patients in the country as such a process normally required a large number of patients.
KUALA LUMPUR: Pharmaniaga Berhad, a prospect to distribute Covid-19 vaccine, said it will not be making substantial investment for the bottling of the vaccine at is plant in Puchong.
KUALA LUMPUR: The selection of companies to package the Covid-19 vaccine, once it is found, will not be limited to Pharmaniaga and Duopharma, the Dewan Rakyat was told today. Khairy said several companies have withdrawn from participating in the clinical trial in Malaysia due to the relatively small number of Covid-19 patients in the country as such a process normally required a large number of patients.
KUALA LUMPUR: Pharmaniaga Berhad, a prospect to distribute Covid-19 vaccine, said it will not be making substantial investment for the bottling of the vaccine at is plant in Puchong.
KUALA LUMPUR: The selection of companies to package the Covid-19 vaccine, once it is found, WILL NOT BE LIMITED to Pharmaniaga and Duopharma, the Dewan Rakyat was told today. Khairy said several companies have WITHDRAWN from participating in the clinical trial in Malaysia DUE TO THE RELATIVELY SMALL NUMBER OF COVID-19 PATIENTS IN THE COUNTRY as such a process normally required a large number of patients
Pengadil Korang ni ntah pape je. Boleh tanya kenapa 2mil? Buat apa 100mil kalau itu je kos adjust yg perlu invest
Gloves have fundamentals and remain strong. Not like Pharma owned by some UMNO people and ask their CEO come out two days ago to talk about filling vaccine as if there is Vaccine already (in fact no covid19 vaccine available to public). Their aim is to create market sentiment to gain profit, after two days of pharma stock surge, people wake up from their delusion so come back to glove counters. Too bad for pharma, they will continue to crash even after another rumours about vaccine sooner or later, noone will believe anymore cuz we all heard about the wolves story when we were kids. Dr Fauci say early authorization of vaccine use is dangerous. Dr Hissam says Ministry of Health Malaysia will not approve any covid vaccine which hasn't passed full trial until theres is strong evidence of its efficacy. Believe in doctors, not some politicians or DUMNO people.
Still hoping up again ka ? When vaccine is ready and when can start do bottling ,any agreement and with who ? Invest rm2mil can do what ? Switch to invest glove counter which already making huge profits and strong fundamental.
The rally for pharmaceutical will probably resume tomorrow, after minor correction today. Buy on RUMOURS (Vaccine).
Gloves, on the other hand, will suffer a prolonged downward pressure on both its share prices and ASP, due to increasing competitions from both local and international players, negative sentiments due to vaccine news / windfall tax /FDA queries, overweighted share prices, market saturations, labour shortage, maximised utilisation rate of it's current production facilitie (capped) and fear of unsustainable future earning.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
pang72
51,510 posts
Posted by pang72 > 2020-08-26 17:25 | Report Abuse
Buy more